Previous 10 | Next 10 |
DAVIS, Calif., Feb. 11, 2020 (GLOBE NEWSWIRE) -- Marrone Bio Innovations, Inc. (NASDAQ: MBII) (MBI), an international leader in sustainable bioprotection and plant health solutions, today announced the completion of a study, conducted in cooperation with UC-Davis Graduate School of Manageme...
Novel biofungicide effective on specialty crops for yield-robbing diseases DAVIS, Calif., Jan. 14, 2020 (GLOBE NEWSWIRE) -- Marrone Bio Innovations, Inc. (NASDAQ: MBII) (MBI), an international leader in sustainable bioprotection and plant health solutions, today announced that its nove...
DAVIS, Calif., Jan. 09, 2020 (GLOBE NEWSWIRE) -- Marrone Bio (NASDAQ: MBII) (MBI), an international leader in sustainable bioprotection and plant health solutions, today announced a $13.0 million expansion of its existing accounts-receivable credit facility which now totals $20.0 million, a...
Cellect Biotechnology (NASDAQ: APOP ) +141% on new patents . More news on: Cellect Biotechnology Ltd., Apellis Pharmaceuticals, Inc., Advaxis, Inc., Stocks on the move, Read more ...
DAVIS, Calif., Jan. 07, 2020 (GLOBE NEWSWIRE) -- Marrone Bio Innovations Inc. (NASDAQ: MBII) (MBI), an international leader in sustainable bioprotection and plant health solutions, today announced that two of its biofungicide products—Stargus ® and Regalia ® —have b...
DAVIS, Calif., Dec. 16, 2019 (GLOBE NEWSWIRE) -- Marrone Bio (NASDAQ: MBII) (MBI), an international leader in sustainable bioprotection and plant health solutions, today announced the results of new U.S. field trials of its next-generation nematicide/insecticide, which showed superior contr...
DAVIS, Calif., Dec. 09, 2019 (GLOBE NEWSWIRE) -- Marrone Bio Innovations, Inc. (NASDAQ: MBII) (MBI), an international leader in sustainable bioprotection and plant health solutions, announced today that its 2019 field trial results for biology-based seed treatments in Europe demonstrate...
Marrone Bio Innovations ( MBII -1% ) announced that the company's founder Dr. Pamela Marrone will retire from her position as CEO. More news on: Marrone Bio Innovations, Inc., Read more ...
DAVIS, Calif., Dec. 02, 2019 (GLOBE NEWSWIRE) -- Marrone Bio Innovations, Inc. (NASDAQ: MBII) (MBI), an international leader in sustainable bioprotection and plant health solutions, announced today that company founder Dr. Pamela Marrone will retire from her position as chief executive ...
Marrone Bio Innovations, Inc. (MBII) Q3 2019 Results Conference Call November 12, 2019 04:30 PM ET Company Participants Linda Moore - General Counsel Pam Marrone - CEO Jim Boyd - President and CFO Kevin Hammill - Chief Commercial Officer Conference Call Participants Samee...
News, Short Squeeze, Breakout and More Instantly...
Marrone Bio Innovations Inc. Company Name:
MBII Stock Symbol:
NASDAQ Market:
Marrone Bio Innovations Inc. Website:
ROTH MKM (“Roth”), a relationship-driven investment bank focused on serving growth companies and their investors, today announced that its agribusiness investment banking group has advised on three sellside transactions in the past nine months. According to the announcement, the tr...
RALEIGH, N.C., July 11, 2022 (GLOBE NEWSWIRE) -- Marrone Bio Innovations, Inc. (NASDAQ: MBII) (MBI) announced that during a special shareholder meeting held on July 8, 2022, its shareholders approved a proposal to adopt the previously announced Agreement and Plan of Merger (Merger Agreement...
RALEIGH, N.C., May 11, 2022 (GLOBE NEWSWIRE) -- Marrone Bio Innovations, Inc. (NASDAQ: MBII), an international leader in sustainable bioprotection and plant health solutions, has provided its financial results for the first quarter ended March 31, 2022. Key results include: ...